Prognostic Impact of Non‐Impacted Third Molar Extraction on Non‐Surgical Periodontal Therapy for Adjacent Second Molars: A Prospective Split‐Mouth Study
Journal of Clinical Periodontology · 2025
DOI: 10.1111/jcpe.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, 2025. Verfasst von Rui Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, School of Stomatology, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical …. Hauptthemen laut MEDLINE: Molar, Third, Molar, Tooth Extraction, Periodontitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Young Elite Scientist Sponsorship Program by China Association for Science and Technology.
Abstract (Originalsprache)
Aims
To compare the outcomes of non‐surgical periodontal therapy (NSPT) alone and NSPT plus adjacent non‐impacted third molar (N‐M3) removal on second molars (M2s). Materials and Methods In this prospective split‐mouth study, 40 patients with periodontitis who had N‐M3s on both sides of the same jaw were enrolled. For each patient, a full‐mouth NSPT was performed, with one N‐M3 extracted (N‐M3−) and the other N‐M3 retained (N‐M3+). Periodontal clinical parameters, gingival crevicular fluid (GCF) and subgingival plaque samples were measured/collected before (T0), 3 months after (T1) and 6 months after (T2) the treatment.
Results
All M2s showed improved probing depth after treatment. At T1 and T2, M2s in the N‐M3− group yielded better outcomes in periodontal clinical parameters than the N‐M3+ group, along with a significant decrease in the abundance of periodontal pathogens such as Porphyromonas gingivalis , Prevotella nigrescens and Fusobacterium nucleatum in subgingival plaque. At T2, the M2s in the N‐M3− group had significantly lower GCF volume and higher interleukin‐10 levels than those in the N‐M3+ group.
Conclusion
Over the 6‐month observation period, removal of adjacent N‐M3s enhanced the outcome of NSPT for second molars, as demonstrated clinically, immunologically and microbiologically. Trial Registration: Chinese Clinical Trail Registry (identification number: ChiCTR2300070343). https://www.chictr.org.cn/showproj.html?proj=194830 Date of Registration: April 10th, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Periodontology, School of Stomatology, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi International Joint Researc…
ORCID-Profile: Rui Gao, Fa-Ming Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Young Elite Scientist Sponsorship Program by China Association for Science and Technology
- Natural Science Foundation of Shaanxi Province
Zitieren
APA
Gao, R., Qu, H. L., Tian, Y., Sun, L. J., He, X. T., Tian, B. M., Yin, Y., Chen, F. M., & Wu, R. X. (2025). Prognostic Impact of Non‐Impacted Third Molar Extraction on Non‐Surgical Periodontal Therapy for Adjacent Second Molars: A Prospective Split‐Mouth Study. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.70010
Vancouver
Gao R, Qu HL, Tian Y, Sun LJ, He XT, Tian BM, et al. Prognostic Impact of Non‐Impacted Third Molar Extraction on Non‐Surgical Periodontal Therapy for Adjacent Second Molars: A Prospective Split‐Mouth Study. Journal of Clinical Periodontology. 2025. doi:10.1111/jcpe.70010
BibTeX
@article{Gao2025,
author = {Gao, Rui and Qu, Hong-Lei and Tian, Yi and Sun, Li-Juan and He, Xiao-Tao and Tian, Bei-Min and Yin, Yuan and Chen, Fa-Ming and Wu, Rui-Xin},
title = {Prognostic Impact of Non‐Impacted Third Molar Extraction on Non‐Surgical Periodontal Therapy for Adjacent Second Molars: A Prospective Split‐Mouth Study},
journal = {Journal of Clinical Periodontology},
year = {2025},
doi = {10.1111/jcpe.70010}
}
EUVIMED